For the year ending 2025-12-31, HHS had -$4,347K decrease in cash & cash equivalents over the period. -$4,492K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -811 |
| Depreciation and amortization expense | 4,472 |
| Restructuring expense | 0 |
| Impairment charges for goodwill and intangible assets | 0 |
| Stock-based compensation | 258 |
| Net pension cost | -2,343 |
| Deferred income taxes | -928 |
| Accounts receivable, net and contract assets | -4,973 |
| Prepaid expenses, income tax receivable and other current assets | 1,885 |
| Accounts payable and accrued expenses | -3,210 |
| Deferred revenue and customer advances | -776 |
| Customer postage and program deposits | 757 |
| Other accrued expenses and liabilities | -728 |
| Net cash used in operating activities | -1,735 |
| Purchases of property, plant and equipment | 2,757 |
| Proceeds from the sale of property, plant and equipment | 1 |
| Net cash used in investing activities | -2,756 |
| Debt financing costs | 100 |
| Payment of finance leases | 159 |
| Recovery of short-swing profit from stockholders | 838 |
| Treasury stock activities | -65 |
| Net cash provided by (used in) financing activities | 514 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -370 |
| Net decrease in cash and cash equivalents and restricted cash | -4,347 |
| Cash and cash equivalents and restricted cash at beginning of year | 9,934 |
| Cash and cash equivalents and restricted cash at end of year | 5,587 |
HARTE HANKS INC (HHS)
HARTE HANKS INC (HHS)